Bioincept Overview

  • Founded
  • 2001
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $3.1M
Latest Deal Amount
  • Investors
  • 1

Bioincept General Information


Developer of transformative therapeutic and diagnostic products designed to pursue and prioritize a range of clinical protocols in the areas of autoimmunity, neuro-regeneration, transplantation, oncology and pregnancy. The company's products focus on the development of pre-implantation factor-based products, enabling patients to improve outcomes who are receiving in-vitro fertilization treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Therapeutic Devices
Other Industries
Drug Discovery
Diagnostic Equipment
Primary Office
  • 1697 Lark Lane
  • Cherry Hill, NJ 08003
  • United States
+1 (856) 000-0000

Bioincept Timeline

Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioincept Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Angel (individual) 19-Oct-2020 $3.1M 000.00 Completed Generating Revenue
5. Angel (individual) 06-Feb-2019 00.000 000.00 Completed Generating Revenue
4. Angel (individual) 01-Dec-2016 00.000 000.00 Completed Generating Revenue
3. Grant 01-Jan-2016 00000 00.000 Completed Generating Revenue
2. Angel (individual) 25-Apr-2014 $3.19M $4.79M Completed Generating Revenue
1. Angel (individual) 22-May-2007 $1.6M $1.6M Completed Generating Revenue
To view Bioincept’s complete valuation and funding history, request access »

Bioincept Executive Team (3)

Name Title Board Seat Contact Info
Brian Foster Chief Executive Officer & President
Eytan Barnea Co-Founder, Chief Scientific Officer & Board Member
Jacqueline Barnea Ph.D Co-Founder & Chairman of the Board
To view Bioincept’s complete executive team members history, request access »

Bioincept Board Members (7)

Name Representing Role Since
Barton O Brien Self Board Member 000 0000
David Duncan Self Board Member 000 0000
Dennis Spink Self Board Member 000 0000
Eytan Barnea Bioincept Co-Founder, Chief Scientific Officer & Board Member 000 0000
George Frank Jr. Bioincept Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Bioincept Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
To view Bioincept’s complete investors history, request access »